Greenwich LifeSciences, Inc.
corporate_fare Company Profile
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 10 items for GLSI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for GLSI spans 10-Q, 10-K.
Recent high-impact activity:
- Greenwich LifeSciences Q3 Loss Widens to $5.8M; Cash Falls to $5.9M With Going Concern Warning
- Greenwich LifeSciences Q2 Loss Widens to $3.95M; Cash at $8.88M, Going Concern Warning Reiterated
- UK Regulators Approve FLAMINGO-01 Expansion, Adding 5-10 Sites
- EMA Greenlights Combined HLA Enrollment in FLAMINGO-01, Doubling Potential Market
- Preliminary Phase III Data Shows 70-80% Recurrence Reduction for Greenwich LifeSciences' GP2
Financial Snapshot
Short Interest & Short Volume
12.51 days to coverFINRA reported short interest of 1,578,166 shares in GLSI as of the October 30, 2026 settlement, a 1.7% increase from the prior period — about 12.5 days to cover at its recent average daily volume. On November 20, 2026, 78.3% of GLSI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.